Cure of multifocal panhepatic hepatoblastoma: is liver transplantation always necessary?

Journal of Pediatric Surgery

Volumn 45, Issue 5, 2010, Pages 1030-1036

  Baertschiger, Reto Marc ^a,b   Ozsahin, Hulya ^a   Rougemont, Anne Laure ^b   Anooshiravani, Mehrak ^a   Rubbia Brandt, Laura ^b   Le Coultre, Claude ^a   Majno, Pietro ^b   Wildhaber, Barbara E ^a   Mentha, Gilles ^b   Chardot, Christophe ^a,c  

^a Hopital des Enfants Hopitaux universitaires de Geneve   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Hepatoblastoma; Liver transplantation; Prognosis; Surgery

Indexed keywords

CARBOPLATIN; CISPLATIN; DOXORUBICIN;

ADOLESCENT; ARTICLE; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER MORTALITY; CANCER RECURRENCE; CASE REPORT; CHILD; CHILD CARE; CLINICAL PROTOCOL; HEPATOBLASTOMA; HUMAN; LIVER RESECTION; LIVER TRANSPLANTATION; LUNG METASTASIS; MALE; MEDIASTINUM METASTASIS; MEDICAL SOCIETY; MULTIFOCAL PANHEPATIC HEPATOBLASTOMA; PATIENT REFERRAL; PREOPERATIVE CARE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROGNOSIS; TREATMENT INDICATION; TREATMENT OUTCOME;

CHEMOTHERAPY, ADJUVANT; CHILD, PRESCHOOL; HEPATECTOMY; HEPATOBLASTOMA; HUMANS; INFANT; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; SWITZERLAND; TOMOGRAPHY, X-RAY COMPUTED;

EID: 77951614432     PISSN: 00223468     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpedsurg.2010.01.038     Document Type: Article

References (59)

1. Linabery A.M., and Ross J.A. Trends in childhood cancer incidence in the U.S. (1992-2004). Cancer 112 (2008) 416-432
2. Czauderna P., Otte J.B., Aronson D.C., et al. Guidelines for surgical treatment of hepatoblastoma in the modern era-recommendations from the Childhood Liver Tumour Strategy Group of the International Society of Paediatric Oncology (SIOPEL). Eur J Cancer 41 (2005) 1031-1036
3. Aronson D.C., Schnater J.M., Staalman C.R., et al. Predictive value of the pretreatment extent of disease system in hepatoblastoma: results from the International Society of Pediatric Oncology Liver Tumor Study Group SIOPEL-1 study. J Clin Oncol 23 (2005) 1245-1252
4. Otte J.B., Pritchard J., Aronson D.C., et al. Liver transplantation for hepatoblastoma: results from the International Society of Pediatric Oncology (SIOP) study SIOPEL-1 and review of the world experience. Pediatr Blood Cancer 42 (2004) 74-83
5. Perilongo G., Shafford E., Maibach R., et al. Risk-adapted treatment for childhood hepatoblastoma. final report of the second study of the International Society of Paediatric Oncology-SIOPEL 2. Eur J Cancer 40 (2004) 411-421
6. Perilongo G., Shafford E., and Plaschkes J. SIOPEL trials using preoperative chemotherapy in hepatoblastoma. Lancet Oncol 1 (2000) 94-100
7. Roebuck D.J., Aronson D., Clapuyt P., et al. 2005 PRETEXT: a revised staging system for primary malignant liver tumours of childhood developed by the SIOPEL group. Pediatr Radiol 37 (2007) 123-132 [quiz 249-150]
8. Schnater J.M., Aronson D.C., Plaschkes J., et al. Surgical view of the treatment of patients with hepatoblastoma: results from the first prospective trial of the International Society of Pediatric Oncology Liver Tumor Study Group. Cancer 94 (2002) 1111-1120
9. Langevin A.M., Pierro A., Liu P., et al. Adriamycin and cis-platinum administered by continuous infusion preoperatively in hepatoblastoma unresectable at presentation. Med Pediatr Oncol 18 (1990) 181-184
10. Soltys K.A., Mazariegos G.V., Squires R.H., et al. Late graft loss or death in pediatric liver transplantation: an analysis of the SPLIT database. Am J Transplant 7 (2007) 2165-2171
11. Otte J.B., Aronson D., Vraux H., et al. Preoperative chemotherapy, major liver resection, and transplantation for primary malignancies in children. Transplant Proc 28 (1996) 2393-2394
12. Nadalin S., Heuer M., Wallot M., et al. Paediatric acute liver failure and transplantation: the University of Essen experience. Transpl Int 20 (2007) 519-527
13. Rhee C., Narsinh K., Venick R.S., et al. Predictors of clinical outcome in children undergoing orthotopic liver transplantation for acute and chronic liver disease. Liver Transpl 12 (2006) 1347-1356
14. Mahadeb P., Gras J., Sokal E., et al. Liver transplantation in children with fulminant hepatic failure: the UCL experience. Pediatr Transplant 13 (2009) 414-420
15. Otte J.B., de Ville de Goyet J., and Reding R. Liver transplantation for hepatoblastoma: indications and contraindications in the modern era. Pediatr Transplant 9 (2005) 557-565
16. Avila L.F., Luis A.L., Hernandez F., et al. Liver transplantation for malignant tumours in children. Eur J Pediatr Surg 16 (2006) 411-414
17. Otte J.B., Janssen M., Rosati M.R., et al. Parental experience with living-related donor liver transplantation. Pediatr Transplant 8 (2004) 317-321
18. Reding R., de Goyet Jde V., Delbeke I., et al. Pediatric liver transplantation with cadaveric or living related donors: comparative results in 90 elective recipients of primary grafts. J Pediatr 134 (1999) 280-286
19. Pritchard J., Brown J., Shafford E., et al. Cisplatin, doxorubicin, and delayed surgery for childhood hepatoblastoma: a successful approach-results of the first prospective study of the International Society of Pediatric Oncology. J Clin Oncol 18 (2000) 3819-3828
20. Rana A.N., Qidwai A., Pritchard J., et al. Successful treatment of multifocal unresectable hepatoblastoma with chemotherapy only. Pediatr Hematol Oncol 23 (2006) 153-158
21. Nishimura S., Sato T., Fujita N., et al. High-dose chemotherapy in children with metastatic hepatoblastoma. Pediatr Int 44 (2002) 300-305
22. Tagge E.P., Tagge D.U., Reyes J., et al. Resection, including transplantation, for hepatoblastoma and hepatocellular carcinoma: impact on survival. J Pediatr Surg 27 (1992) 292-296 [discussion 297]
23. Reyes J.D., Carr B., Dvorchik I., et al. Liver transplantation and chemotherapy for hepatoblastoma and hepatocellular cancer in childhood and adolescence. J Pediatr 136 (2000) 795-804
24. Casas-Melley A.T., Malatack J., Consolini D., et al. Successful liver transplant for unresectable hepatoblastoma. J Pediatr Surg 42 (2007) 184-187
25. Andres A.M., Hernandez F., Lopez-Santamaria M., et al. Surgery of liver tumors in children in the last 15 years. Eur J Pediatr Surg 17 (2007) 387-392
26. von Schweinitz D. Management of liver tumors in childhood. Semin Pediatr Surg 15 (2006) 17-24
27. Czauderna P., Otte J.B., Roebuck D.J., et al. Surgical treatment of hepatoblastoma in children. Pediatr Radiol 36 (2006) 187-191
28. Chen L.E., Shepherd R.W., Nadler M.L., et al. Liver transplantation and chemotherapy in children with unresectable primary hepatic malignancies: development of a management algorithm. J Pediatr Gastroenterol Nutr 43 (2006) 487-493
29. Tiao G.M., Bobey N., Allen S., et al. The current management of hepatoblastoma: a combination of chemotherapy, conventional resection, and liver transplantation. J Pediatr 146 (2005) 204-211
30. Austin M.T., Leys C.M., Feurer I.D., et al. Liver transplantation for childhood hepatic malignancy: a review of the United Network for Organ Sharing (UNOS) database. J Pediatr Surg 41 (2006) 182-186
31. Pimpalwar A.P., Sharif K., Ramani P., et al. Strategy for hepatoblastoma management: transplant versus nontransplant surgery. J Pediatr Surg 37 (2002) 240-245
32. Dall'Igna P., Cecchetto G., Toffolutti T., et al. Multifocal hepatoblastoma: is there a place for partial hepatectomy?. Med Pediatr Oncol 40 (2003) 113-116 [discussion 116-117]
33. Brown J., Perilongo G., Shafford E., et al. Pretreatment prognostic factors for children with hepatoblastoma-results from the International Society of Paediatric Oncology (SIOP) study SIOPEL 1. Eur J Cancer 36 (2000) 1418-1425
34. D'Antiga L., Vallortigara F., Cillo U., et al. Features predicting unresectability in hepatoblastoma. Cancer 110 (2007) 1050-1058
35. Fuchs J., Rydzynski J., Von Schweinitz D., et al. Pretreatment prognostic factors and treatment results in children with hepatoblastoma: a report from the German Cooperative Pediatric Liver Tumor Study HB 94. Cancer 95 (2002) 172-182
36. Hata Y. The clinical features and prognosis of hepatoblastoma: follow-up studies done on pediatric tumors enrolled in the Japanese Pediatric Tumor Registry between 1971 and 1980. Part I. Committee of Malignant Tumors, Japanese Society of Pediatric Surgeons. Jpn J Surg 20 (1990) 498-502
37. Sasaki F., Matsunaga T., Iwafuchi M., et al. Outcome of hepatoblastoma treated with the JPLT-1 (Japanese Study Group for Pediatric Liver Tumor) Protocol-1: A report from the Japanese Study Group for Pediatric Liver Tumor. J Pediatr Surg 37 (2002) 851-856
38. von Schweinitz D., Wischmeyer P., Leuschner I., et al. Clinico-pathological criteria with prognostic relevance in hepatoblastoma. Eur J Cancer 30A (1994) 1052-1058
39. Ortega J.A., Douglass E.C., Feusner J.H., et al. Randomized comparison of cisplatin/vincristine/fluorouracil and cisplatin/continuous infusion doxorubicin for treatment of pediatric hepatoblastoma: a report from the Children's Cancer Group and the Pediatric Oncology Group. J Clin Oncol 18 (2000) 2665-2675
40. Gras J.M., Gerkens S., Beguin C., et al. Steroid-free, tacrolimus-basiliximab immunosuppression in pediatric liver transplantation: clinical and pharmacoeconomic study in 50 children. Liver Transpl 14 (2008) 469-477
41. Campbell K.M., Yazigi N., Ryckman F.C., et al. High prevalence of renal dysfunction in long-term survivors after pediatric liver transplantation. J Pediatr 148 (2006) 475-480
42. Arora-Gupta N., Davies P., McKiernan P., et al. The effect of long-term calcineurin inhibitor therapy on renal function in children after liver transplantation. Pediatr Transplant 8 (2004) 145-150
43. McLin V.A., Girardin E., Lecoultre C., et al. Glomerular and tubular function following orthotopic liver transplantation in children. Pediatr Transplant 9 (2005) 512-519
44. Law Y.M., Yim R., Agatisa P., et al. Lipid profiles in pediatric thoracic transplant recipients are determined by their immunosuppressive regimens. J Heart Lung Transplant 25 (2006) 276-282
45. Siirtola A., Antikainen M., Ala-Houhala M., et al. Serum lipids in children 3 to 5 years after kidney, liver, and heart transplantation. Transpl Int 17 (2004) 109-119
46. Siirtola A., Antikainen M., Ala-Houhala M., et al. Insulin resistance, LDL particle size, and LDL susceptibility to oxidation in pediatric kidney and liver recipients. Kidney Int 67 (2005) 2046-2055
47. Siirtola A., Solakivi T., Jokela H., et al. Hypertriglyceridemia and low serum HDL cholesterol are common in children after liver transplantation. Transplant Proc 33 (2001) 2449
48. Jain A., Nalesnik M., Reyes J., et al. Posttransplant lymphoproliferative disorders in liver transplantation: a 20-year experience. Ann Surg 236 (2002) 429-436 [discussion 436-427]
49. Nathanson S., Debray D., Delarue A., et al. Long-term survival after post-transplant lymphoproliferative disease in children. Pediatr Nephrol 17 (2002) 668-672
50. Norin S., Kimby E., Ericzon B.G., et al. Posttransplant lymphoma-a single-center experience of 500 liver transplantations. Med Oncol 21 (2004) 273-284
51. Younes B.S., McDiarmid S.V., Martin M.G., et al. The effect of immunosuppression on posttransplant lymphoproliferative disease in pediatric liver transplant patients. Transplantation 70 (2000) 94-99
52. Gerber D.A., Green M., Jaffe R., et al. Cryptosporidial infections after solid organ transplantation in children. Pediatr Transplant 4 (2000) 50-55
53. Pacini-Edelstein S.J., Mehra M., Ament M.E., et al. Varicella in pediatric liver transplant patients: a retrospective analysis of treatment and outcome. J Pediatr Gastroenterol Nutr 37 (2003) 183-186
54. Verma A., Wade J.J., Cheeseman P., et al. Risk factors for fungal infection in paediatric liver transplant recipients. Pediatr Transplant 9 (2005) 220-225
55. Riva S., Sonzogni A., Bravi M., et al. Late graft dysfunction and autoantibodies after liver transplantation in children: preliminary results of an Italian experience. Liver Transpl 12 (2006) 573-577
56. Cairo S., Armengol C., De Reynies A., et al. Hepatic stem-like phenotype and interplay of Wnt/beta-catenin and Myc signaling in aggressive childhood liver cancer. Cancer Cell 14 (2008) 471-484
57. Curia M.C., Zuckermann M., De Lellis L., et al. Sporadic childhood hepatoblastomas show activation of beta-catenin, mismatch repair defects and p53 mutations. Mod Pathol 21 (2008) 7-14
58. Hiyama E., Yamaoka H., Matsunaga T., et al. High expression of telomerase is an independent prognostic indicator of poor outcome in hepatoblastoma. Br J Cancer 91 (2004) 972-979
59. Sugawara W., Haruta M., Sasaki F., et al. Promoter hypermethylation of the RASSF1A gene predicts the poor outcome of patients with hepatoblastoma. Pediatr Blood Cancer 49 (2007) 240-249